ASXS: Yes the neoantigen vaccine had me going till I read this link posted here last year, which suggested that ADXS's approach must also possibly wait for other outcome interventions to re-adjust (customize) the bio-environment for a patient to be most receptive to this neo-antigen approach. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143963471&txt2find=adxs
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.